X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19043) 19043
Newsletter (5642) 5642
Book Review (2840) 2840
Newspaper Article (1690) 1690
Publication (740) 740
Magazine Article (670) 670
Transcript (320) 320
Trade Publication Article (108) 108
Conference Proceeding (106) 106
Dissertation (28) 28
Book / eBook (22) 22
Book Chapter (19) 19
Streaming Video (13) 13
Web Resource (10) 10
Government Document (5) 5
Reference (3) 3
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15264) 15264
humans (13321) 13321
anticholesteremic agents (13201) 13201
anticholesteremic agents - therapeutic use (8479) 8479
male (8374) 8374
cholesterol (7366) 7366
female (6348) 6348
middle aged (5199) 5199
animals (4730) 4730
anticholesteremic agents - pharmacology (4464) 4464
aged (3724) 3724
research (3577) 3577
hypercholesterolemia - drug therapy (3496) 3496
adult (3307) 3307
cholesterol - blood (3203) 3203
hypercholesterolemia (3152) 3152
cholesterol, ldl - blood (3108) 3108
risk factors (2983) 2983
abridged index medicus (2578) 2578
anticholesteremic agents - administration & dosage (2509) 2509
low density lipoproteins (2501) 2501
statins (2483) 2483
atherosclerosis (2334) 2334
cardiovascular agents (2275) 2275
rats (2239) 2239
cardiac & cardiovascular systems (2205) 2205
pharmacology & pharmacy (2192) 2192
anticholesteremic agents - adverse effects (2031) 2031
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2023) 2023
drug therapy (1988) 1988
simvastatin (1985) 1985
treatment outcome (1983) 1983
reports (1814) 1814
medicine, general & internal (1770) 1770
lipids (1767) 1767
analysis (1759) 1759
pharmaceutical industry (1716) 1716
atorvastatin calcium (1713) 1713
medical research (1708) 1708
prevention (1612) 1612
care and treatment (1597) 1597
triglycerides - blood (1539) 1539
ezetimibe (1468) 1468
hypercholesterolemia - blood (1457) 1457
medicine, experimental (1429) 1429
health aspects (1413) 1413
drug therapy, combination (1384) 1384
cholesterol, hdl - blood (1366) 1366
cardiovascular disease (1364) 1364
coronary heart disease (1277) 1277
lipids - blood (1239) 1239
mice (1226) 1226
cholesterol - metabolism (1216) 1216
pravastatin (1210) 1210
atorvastatin (1209) 1209
peripheral vascular disease (1208) 1208
coronary-heart-disease (1161) 1161
physiological aspects (1159) 1159
heptanoic acids - therapeutic use (1126) 1126
double-blind method (1111) 1111
risk (1105) 1105
cardiovascular diseases (1100) 1100
cardiovascular diseases - prevention & control (1090) 1090
pyrroles - therapeutic use (1084) 1084
diabetes (1073) 1073
biochemistry & molecular biology (1063) 1063
blood cholesterol (1059) 1059
simvastatin - therapeutic use (997) 997
cardiology (987) 987
hyperlipidemias - drug therapy (982) 982
diet (966) 966
coronary disease - prevention & control (938) 938
dose-response relationship, drug (938) 938
time factors (926) 926
clinical trials (913) 913
liver - metabolism (903) 903
drugs (887) 887
antilipemic agents (855) 855
disease (853) 853
metabolism (845) 845
pravastatin - therapeutic use (825) 825
mortality (821) 821
lipoproteins (819) 819
clinical trials as topic (815) 815
universities and colleges (815) 815
endocrinology & metabolism (783) 783
azetidines - therapeutic use (762) 762
cardiac patients (758) 758
cardiovascular-disease (754) 754
therapy (747) 747
nutrition & dietetics (744) 744
hypercholesterolemia - complications (743) 743
lovastatin - therapeutic use (733) 733
liver - drug effects (730) 730
myocardial-infarction (726) 726
cardiovascular (725) 725
randomized controlled trials as topic (725) 725
hypolipidemic agents - therapeutic use (714) 714
triglycerides (698) 698
aged, 80 and over (670) 670
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (13) 13
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25323) 25323
German (484) 484
French (301) 301
Russian (212) 212
Spanish (188) 188
Italian (161) 161
Japanese (127) 127
Swedish (102) 102
Chinese (96) 96
Polish (80) 80
Norwegian (74) 74
Danish (73) 73
Dutch (66) 66
Hungarian (40) 40
Portuguese (35) 35
Czech (33) 33
Finnish (14) 14
Hebrew (10) 10
Romanian (9) 9
Turkish (7) 7
Ukrainian (6) 6
Croatian (4) 4
Lithuanian (3) 3
Bulgarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1975, ISBN 9780387073613, Volume 41. Bd., xiii, 488
Book
1970, 1st ed., International encyclopedia of pharmacology and therapeutics, ISBN 008006633X, Volume section 13., v.
Book
Journal of Controlled Release, ISSN 0168-3659, 2010, Volume 148, Issue 3, pp. 303 - 310
The chronic inflammatory environment of tumors is a target for novel antitumor therapeutic strategies. Besides cholesterol lowering effects, statins have been... 
Liposome | MHC class I | Angiogenesis | Inflammation | Statin | Cancer | LOVASTATIN | INDUCED APOPTOSIS | MACROPHAGES | INSIGHT | STATINS | CHEMISTRY, MULTIDISCIPLINARY | THERAPY | ANTIINFLAMMATORY AGENTS | LIPID RAFTS | HUMAN-MELANOMA CELLS | PHARMACOLOGY & PHARMACY | Genes, MHC Class I - drug effects | Humans | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Neoplasms - complications | Neoplasms - genetics | Inflammation - drug therapy | Angiogenic Proteins - immunology | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Pravastatin - therapeutic use | Cytokines - immunology | Pravastatin - pharmacology | Cell Survival - drug effects | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Inflammation - etiology | Neoplasms - drug therapy | Anticholesteremic Agents - pharmacokinetics | Animals | Anticholesteremic Agents - therapeutic use | Pravastatin - administration & dosage | Neoplasms - immunology | Anticholesteremic Agents - administration & dosage | Lipid Metabolism - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Liposomes | Anticholesteremic Agents - pharmacology | Pravastatin - pharmacokinetics | Proteins | Post-translational modification | Cell research | Care and treatment | Growth | Physiological aspects | Pravastatin | Tumors | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 11/2013, Volume 15, Issue 11, pp. 1040 - 1048
AimsPostprandial triglyceridaemia is a risk factor for cardiovascular disease (CVD). This study investigated the effects of steady-state liraglutide 1.8mg... 
lipid‐lowering therapy | study | randomized trial | 1 analogue | antidiabetic drug | GLP | phase I | type | diabetes | Type II diabetes | Randomized trial | Antidiabetic drug | Lipid-lowering therapy | GLP-1 analogue | Phase I-II study | LIPEMIA | OXIDATIVE STRESS | RECEPTOR AGONISTS | EXENATIDE | ACID BREATH TEST | INSULIN RESPONSES | MELLITUS | type II diabetes | lipid-lowering therapy | phase I-II study | THERAPY | GLUCOSE | ENDOCRINOLOGY & METABOLISM | GLUCAGON | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Diet, High-Fat - adverse effects | Half-Life | Glucagon-Like Peptide 1 - blood | Male | Hypoglycemic Agents - blood | Cardiovascular Diseases - complications | Hypolipidemic Agents - blood | Lipids - blood | Postprandial Period | Cardiovascular Diseases - epidemiology | Female | Glucagon-Like Peptide 1 - pharmacokinetics | Diabetes Mellitus, Type 2 - complications | Hyperlipidemias - complications | Body Mass Index | Hypoglycemic Agents - therapeutic use | Hypolipidemic Agents - adverse effects | Hypoglycemic Agents - pharmacokinetics | Double-Blind Method | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Risk Factors | Hyperlipidemias - prevention & control | Germany - epidemiology | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Gastric Emptying - drug effects | Hyperlipidemias - etiology | Denmark - epidemiology | Aged | Hypolipidemic Agents - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypolipidemic Agents - pharmacokinetics | Hypoglycemic Agents - adverse effects | Liraglutide | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Low density lipoproteins | Anticholesteremic agents | Clinical trials | Triglycerides | Glucose | Fatty acids | Cholesterol | Dextrose | Glucose metabolism | Hypoglycemic agents | Diabetes therapy | Lipids | Diet | Apolipoproteins | Index Medicus
Journal Article
2011, Nursing education in video
The goal of this program is to define and discuss heart failure medications, including digoxen and various types of diuretics. The program also reviews... 
Heart | Treatment | Anticholesteremic agents | Diseases
Web Resource
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 11/2017, Volume 95, pp. 1749 - 1758
Dyslipidemia, oxidative stress and inflammation are major risky factors involved in the pathophysiology of type 2 diabetes mellitus and atherosclerosis.... 
Antihyperlipidemia | Antioxidant | Hydroxytyrosol-fenofibrate | Anti-diabetes | Anti-inflammation | MEDICINE, RESEARCH & EXPERIMENTAL | TRIGLYCERIDE | OXIDATIVE STRESS | HIGH-FAT DIET | PHENOLIC-COMPOUNDS | ALPHA | HYPERTRIGLYCERIDEMIA | METABOLISM | OLIVE OIL | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | AGENTS | Diabetes Mellitus, Experimental - drug therapy | Phenylethyl Alcohol - administration & dosage | Antioxidants - chemistry | Phenylethyl Alcohol - analogs & derivatives | Male | Fenofibrate - chemistry | Fenofibrate - pharmacology | Hypoglycemic Agents - administration & dosage | Drug Design | Anti-Inflammatory Agents - administration & dosage | Hypolipidemic Agents - chemistry | Anti-Inflammatory Agents - pharmacology | Fenofibrate - administration & dosage | Hypoglycemic Agents - chemistry | Antioxidants - pharmacology | Hypolipidemic Agents - pharmacology | Chemistry, Pharmaceutical | Mice, Inbred ICR | Hypoglycemic Agents - pharmacology | Phenylethyl Alcohol - pharmacology | Animals | Anti-Inflammatory Agents - chemistry | Antioxidants - administration & dosage | Hypolipidemic Agents - administration & dosage | Mice | Oxidative Stress - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Phenylethyl Alcohol - chemistry | Antioxidants | Anti-inflammatory drugs | Anticholesteremic agents | Type 2 diabetes | Analysis | Pharmacy | Atherosclerosis | Drugstores | Triglycerides | Index Medicus
Journal Article
1999, Lung biology in health and disease, ISBN 9780824719593, Volume 134., xii, 212
This comprehensive collection discusses anticholinergic agents, integrating the treatment of rhinitis, the common cold, and asthma in the upper and lower... 
Chemotherapy | Respiratory organs | Muscarinic receptors | Parasympatholytic agents | Bronchodilator agents | Asthma | Diseases
Book
2009, ISBN 9780195323573, xvii, 201
Book
Journal of Ethnopharmacology, ISSN 0378-8741, 10/2011, Volume 138, Issue 1, pp. 111 - 118
: Berberine is an isoquinoline alkaloid isolated from the root and bark of plants such as goldenseal, , and Chinese goldthread. Berberine-containing crude... 
Berberine | Liver | Drug–drug interactions | Drug-drug interactions | CHEMISTRY, MEDICINAL | RATS | GOLDENSEAL | MOUSE-LIVER | INDUCTION | PLANT SCIENCES | INHIBITION | KAVA-KAVA | PPAR | METABOLISM | INTEGRATIVE & COMPLEMENTARY MEDICINE | INSULIN-RESISTANCE | IN-VIVO | PHARMACOLOGY & PHARMACY | Antihypertensive Agents - pharmacology | Berberine - administration & dosage | Gene Expression - drug effects | Plant Extracts - pharmacology | Antihypertensive Agents - administration & dosage | Cytochrome P-450 Enzyme System - metabolism | Male | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Plant Extracts - administration & dosage | Hypoglycemic Agents - administration & dosage | Liver - drug effects | Plants, Medicinal - chemistry | Administration, Oral | Mice, Inbred C57BL | Anticholesteremic Agents - adverse effects | Antihypertensive Agents - adverse effects | Hypoglycemic Agents - pharmacology | Berberine - pharmacology | Animals | Anticholesteremic Agents - administration & dosage | Herb-Drug Interactions | Cytochrome P-450 Enzyme System - genetics | Mice | Berberine - adverse effects | Hypoglycemic Agents - adverse effects | Anticholesteremic Agents - pharmacology | Plant Extracts - adverse effects | Phosphates | Pharmacogenetics | Messenger RNA | Drug interactions | Cytochrome P-450 | Mass spectrometry | Sugars | Monosaccharides | Drugs | Hypertension | Enzymes | Cytochrome P450 | Diabetes mellitus | Roots | Bark | Oral administration | Antimicrobial agents | CYP1A2 protein | Gene expression | Nuclear receptors | Risk factors | Infection | Alkaloids | Hypercholesterolemia | Index Medicus | liver | drug-drug interactions
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 01/2016, Volume 25, Issue 1, pp. 90 - 99
Purpose Double medication is defined as the unintended overlapping prescription of two identical substances with the same route of administration by two... 
hyperlipidemia | drug utilization | duplicate prescription | anatomical therapeutic chemical (ATC) classification system | diabetes mellitus | hypertension | pharmacoepidemiology | Hypertension | Pharmacoepidemiology | Hyperlipidemia | Diabetes mellitus | Drug utilization | Anatomical therapeutic chemical (ATC) classification system | Duplicate prescription | ADHERENCE | INTERVENTIONS | NONADHERENCE | PHARMACOLOGY & PHARMACY | PATIENT | HEALTH-CARE | Hypoglycemic Agents - therapeutic use | Prevalence | Hypoglycemic Agents - economics | Humans | Hyperlipidemias - drug therapy | Diabetes Mellitus - drug therapy | Inappropriate Prescribing - statistics & numerical data | Antihypertensive Agents - administration & dosage | Austria - epidemiology | Hypertension - drug therapy | Inappropriate Prescribing - prevention & control | Antihypertensive Agents - therapeutic use | Hyperlipidemias - epidemiology | Drug Prescriptions - statistics & numerical data | Hypolipidemic Agents - economics | Drug Costs - statistics & numerical data | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus - epidemiology | Hypolipidemic Agents - administration & dosage | Patient Safety | Hypolipidemic Agents - therapeutic use | Hypertension - epidemiology | Antihypertensive Agents - economics | Cohort Studies | Hypoglycemic agents | Analysis | Anticholesteremic agents | Prevalence studies (Epidemiology) | Medical care, Cost of | Pharmacology | Internal medicine | Hypoglycemia | Index Medicus
Journal Article
2007, 1st ed., ISBN 9780123739797, xx, 227 p., [3] p. of plates
Today, in the era of the statins (cholesterol lowering drugs), there is no longer any doubt about the value of lowering blood cholesterol levels. This book... 
Hypercholesteremia | Clinical & internal medicine | Hypercholesterolemia - drug therapy
Book
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 07/2010, Volume 20, Issue 14, pp. 4248 - 4251
Novel coumarin derivative as potential lipid lowering agents. A series of novel benzocoumarin derivatives were synthesized and evaluated for their in vivo... 
Benzocoumarins | Cholesterol lowering | Synthesis | Antioxidant | Antidyslipidemic | PATHOGENESIS | CHEMISTRY, MEDICINAL | DENSITY-LIPOPROTEIN | CHEMISTRY, ORGANIC | Coumarins - chemistry | Dyslipidemias - drug therapy | Humans | Coumarins - therapeutic use | Anticholesteremic agents | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539